<DOC>
<DOCNO>
EP-0016277
</DOCNO>
<TEXT>
<DATE>
19801001
</DATE>
<IPC-CLASSIFICATIONS>
C07F-5/00 C07D-333/28 A61K-31/38 C07D-333/00 C07D-261/18 C07D-261/00 C07D-333/22 C07D-333/24 C07C-327/22 C07D-333/38 A61K-31/275 C07C-255/53 C07C-255/58 C07C-67/00 C07C-153/11 <main>C07C-121/76</main> C07C-325/00 C07C-327/00 C07C-253/00 C07C-255/00 C07D-295/00 C07D-295/145 C07D-261/08 
</IPC-CLASSIFICATIONS>
<TITLE>
2-carbonyl-3-hydroxy-alkenonitriles, their use as anti-arthritic agents and processes for their preparation.
</TITLE>
<APPLICANT>
american cyanamid company<sep>american cyanamid companyberdan avenuewayne new jersey 06904us<sep>american cyanamid company<sep>
</APPLICANT>
<INVENTOR>
hanifin, john william, jr.<sep>ridge, david nelson<sep>hanifin, john william, jr.2 sunset terracesuffern, new yorkus<sep>ridge, david nelsonold mountain roadupper grandview, new yorkus<sep>hanifin, john william, jr.<sep>ridge, david nelson<sep>hanifin, john william, jr.2 sunset terracesuffern, new yorkus<sep>ridge, david nelsonold mountain roadupper grandview, new yorkus<sep>
</INVENTOR>
<ABSTRACT>
there are disclosed 2-carbonyl-3-hydroxy-2- alkenonit­ riles, their use as anti-arthritic agents and processes for their  preparation.  the active compounds have the formula:    wherein   n is an integer from 1 to 3 inclusive;   m is hydrogen or a pharmaceutically acceptable cation;   r₆ is an alkyl group of 1 to 4 carbons;   r⁰ is one of the following aromatic groups:   (1) the group    in which r₁, r₂, r₃, r₄ and r₅ are the same or different and are  hydrogen, halogen, alkyl having up to 4 carbons, alkoxy hav­ ing up to 4 carbons, trifluoromethyl or trichloromethyl, with  the proviso that when m is the number 0 at least two of r₁, r₂,  r₃, r₄ and r₅ must be hydrogen;   (2) the thienyl moiety    wherein r₇ is hydrogen, an alkyl group of up to 3 carbons,  fluorine, chlorine or bromine;   x is ch₂ 0 or s and m is the number 0 or 1, provided that  when r⁰ is a thienyl moiety then m is o; and the tautomers of  the above compounds.  
</ABSTRACT>
<DESCRIPTION>
title: 2-carbonyl-3-hydroxy-2-alkenonitriles, their use as anti-arthritic agents and processes for their preparation the present invention concerns compounds and compositions useful as anti-inflammatory agents and as inhibitors of the progressive joint deterioration characteristic of arthritic disease, as well as methods and intermediate compounds for preparation thereof, and also methods of meliorating inflammation and of inhibiting joint deterioration in mammals therewith. more particularly, the invention is concerned with 2-carbonyl-3-hydroxy2-alkenonitriles. according to the present invention there is provided 2-carbonyl-3-hydroxy-2-alkenonitriles of the formula: emi1.1 wherein n is an integer from 1 to 3 inclusive; m is hydrogen or a pharmaceutically acceptable cation; r6is an alkyl group of 1 to 4 carbons; ro is one of the following aromatic groups: : (1) the group emi1.2 in which r11 r2 r3, rq and r5 are the same or different and are hydrogen, halogen, alkyl having up to 4 carbons, alkoxy having up to 4 carbons, trifluoroceohyl or trichlpro- methyl, with the proviso that when m is the number 0 at least two of r1, r2, , r4 and r5 must be hydrogen when r6 is methyl and m is the nueber 0 not all of r1, r2, r3, r4 and r5 may be hydrogen; or (2) the thienyl moiety emi2.1 wherein r7 is hydrogen, an alkyl group of up to 3 carbons, fluorine, chlorine or bromine; x is ch2, o or s and m is the number 0 or 1, provided that when r is a thienyl moiety then m is 0; and the tautomers of the above compounds. also provided according to the invention is an anti-arthritic composition in dosage unit form useful for meliorating the inflammation and/or the progressive joint deterioration characteristic of arthritic disease in mammals, comprising from about one milligram to about 250 milligrams per kilogram of body weight per dosage unit of a 2-carbonyl-3-hydroxy-2-alkenonitrile of the formula: emi2.2 wherein n is an integer from 1 to 3 inclusive; m is hydrogen or a pharmaceutically acceptable cation; -r6 is an alkyl group of 1 to 4 carbons; r0 is one of the following aromatic groups: : (1) the group emi2.3 in which r1, r2, r3, r4 and r5 are the same or different and are hydrogen, halogen, alkyl having up to 4 carbons, alkoxy having up to 4 carbons, trifluoromethyl or trichloromethyl, with the proviso that when m is the number 0 at least two of r1, r2, r3, r4 and r5 must be hydrogen; or (2) the thienyl moiety emi3.1 wherein r7 is hydrogen, an alkyl group of up to 3 carbons, fluorine, chlorine or bromine; x is ch2, o or s and m is the number 0 or 1, provided that when r" is a thienyl moiety then m is 0; and the tautomers of the above compounds. further according to the present invention there is provided a method of producing compounds of formula 1, which comprises: (a) reacting an acetonitrile of the formula: emi3.2 with a compound of the emi3.3 wherein r , x, m and r6 are as
</DESCRIPTION>
<CLAIMS>
claims: 1. 2-carbonyl-3-hydroxy-2-alkenonitriles of the formula: emi98.1       wherein  n is- an integer from 1 to 3 inclusive;  m is hydrogen or a pharmaceutically acceptable cation;  r6 is an alkyl group of 1 to 4 carbons;    ro    is one of the following aromatic groups:  (1) the group emi98.2       in which r1,   r2,    r3,   r4    and r5 are the same or different and are hydrogen, halogen, alkyl having up to 4 carbons, alkoxy having up to 4 carbons, trifluoromethyl or trichloromethyl, with the proviso that when m is the number o at least two of r1, r2, r3,   r4    and   r5    must be hydrogen but when r6 is methyl and m is the number 0 not all of r1,   h ,    r3, r4 and r5 may be hydrogen;  or  (2) the thienyl moiety emi98.3       wherein r7 is hydrogen, an alkyl group of up to 3 carbons, fluorine, chlorine or bromine;  x is ch2,   9    or s and m is the number 0 or 1,  provided that when   ro    is a thienyl moiety then m is 0;  and the tautomers of the above compounds.   2. a compound according to claim 1, wherein   ro    is the group: emi99.1       wherein r1,   r2    r3,   r4    and r5 are as defined; and m is the number 0.   3. a compound according to claim 2, wherein one of the radicals r1,   r2,    r3,   r4    and r5 is bromo, chloro, fluoro, trifluoromethyl, methyl or methoxy and the remaining of said radicals are hydrogen; or r1 is methyl, r3 is chloro and r2, r4 and r5 are each hydrogen.   4. a compound according to claim 1, wherein   ro    is a thienyl moiety and m is the number 0.   5. a compound according to claim 4, wherein r7 is hydrogen, chloro, fluoro, methyl or isopropyl.   6. a compound according to claim 1, wherein r  is the group emi99.2       wherein r1, r2, r3, r4 and r5 are as defined; x is ch2 and m is the number 1.      7.    a compound according to claim 6, wherein one or two of the radicals r1, r2, r3, r4 and r5 is chloro and the   remaining    of said radicals are hydrogen; or one of said radicals is fluoro and the remaining of said radicals are hydrogen.     8. a compound according to claim:l, wherein r  is the group: emi100.1       wherein r1, r2, r3,   r4    and r5 are as defined; x is s and m is the number 1.   9. a compound according to claim   8,    wherein one of the radicals r1, r2, r3,   r4    and r5 is bromo, chloro, fluoro, trifluoromethyl, methyl or methoxy and the remaining of said radicals are hydrogen; or all of said radicals are hydrogen.      10.    a compound according to clam 1, wherein   r     is the group: emi100.2       wherein r1, r2, r3, r4 and r5 are as defined; x is 0 and m is the number 1.   11. a compound according to claim 10, wherein one of the radicals r1, r2, r3, r4 and r5 is bromo, chloro, fluoro, methyl or methoxy and the remaining of said radicals are hydrogen; or two of said radicals are   chldro,    the remaining being hydrogen; or two of said radicals are methoxy, the remaining being hydrogen; or all of said radicals are hydrogen.   12. a compound according to any one of the preceding claims, wherein r6 is methyl.   13. a compound according to any one of the. preceding claims7 wherein m is hydrogen, sodium or   triethylammonium    and n is 1, or m is cupric and   n-    is 2.     14. substituted 2-benzoyl-3-substituted-2-alkenonitriles, useful for preparing   oounds    of claim 1 and of formulas i and ii herein, of the formula: emi101.1       wherein y represents the group or or the group emi101.2       r1, r2, r3,   r4    and r5 are each individually selected from hydrogen, halogen, alkyl having from 1 to 4 carbon atoms, alkoxy having from 1 to 4 carbon atoms, trifluoromethyl or trichloromethyl with the proviso that at least two of r1, r2, r3,   r4    and r5 must be hydrogen, r6 is alkyl having from 1 to 4 carbon atoms; r is alkyl having from 1 to 4 carbon atoms; and r' and r" are each hydrogen or alkyl having from 1 to 4 carbon atoms or r' and r" taken together with the associated nitrogen is pyrrolidino, piperidino, morpholino, thiomorpholino or n-methylpiperazino.   15. a compound according to claim 14, wherein y is emi101.3       and all of r1, r2, r3,   r4    and r5 are hydrogen.   16. a compound according to claim 14, wherein y is or and all of r1, r2, r3, r4 and r5 are hydrogen.   17. a compound according to claim 14, wherein r6 is methyl, y is or and at least one of r1, r2, r3, r4 and r5 is other than hydrogen.   18. a compound according to claim 14, wherein y is or wherein r is methyl or ethyl, and three of the radicals r1,   r2,    r3, r4 and r5 are methoxy and the remaining of said radicals are hydrogen; or one of said radicals is fluoro, bromo, trifluoromethyl or chloro, the remaining being hydrogen; and r6 is methyl or ethyl.   19. a   compound    according to claim 14, wherein y is emi101.4        wherein   r    and   r" are    each methyl, ethyl, n-butyl or hydrogen, or taken together are piperidyl, and three of the radicals r1, r2, r3, r4 and   r5    are methoxy and the-   remaining..df    said radicals are hydrogen; or one of   sa-id radicals    is methyl, another is chloro and the remaining-being hydrogen; or two of said radicals are fluoro, the remaining being hydrogen; or one of said radicals is fluoro or chloro, the remaining being hydrogen; and r6 is methyl or ethyl.   20. a compound useful for preparing compounds of claim 1, of the formula:.   wherein emi102.1       drogen, halogen, lower alkyl (c1-c4), lower alkoxy (c1-c4), trifluoromethyl or tri   ch-loromethyl;    r6 is lower alkyl   tcl-c4);    and x is sulfur or oxygen.   21. a compound according to claim 20, wherein r6 is methyl, x is 0 and three of the radicals r1, r2, r3,   r4    and   r5    are chloro, -the remaining of said   ,radicals ¯ being    hydrogen; or two of said radicals are both chloro, both methoxy or both trifluoromethyl, the remaining being   hydrogen    or one of said radicals is chloro,   another    is   methyl    and the remaining are   hydrogen;    or one   ofsaid      radical-s    is bromo,   chloro,    fluoro, methyl, methoxy or trifluoromethyl and the remaining are hydrogen.    22. a compound according to   clair-20-, -wherein    r6 is methyl, x is s and one of the radicals r1, r2, r3, r4 and r5 is chloro, fluoro, methyl or methoxy, and the remaining of said radicals are hydrogen; or all -of said radicals are hydrogen.   23. an anti-arthritic composition useful in -inhibiting the progression of arthritis, meliorating inflammation and/or inhibiting progressive joint deterioration in mammels, comprising a pharmaceutically acceptable carrier or diluent and a   2-carbonyl-3-hydroxy-2.-alkenonitrile.    of the   formula:    emi102.2         wherein  n is an integer from 1 to 3 inclusive;  m is hydrogen or a pharmaceutically acceptable cation;  r6 is an alkyl group of 1 to 4 carbons;    ro    is one of the following aromatic groups: :  (1) the group emi103.1       in which r1,   r2,    r3, r4 and r5 are the same or different and are hydrogen, halogen, alkyl having up to 4 carbons, alkoxy having up to 4 carbons, trifluoromethyl or trichloromethyl, with the proviso that when m is the number o at least two of r1, r2, r3, r4 and r5 must be hydrogen; or  (2) the thienyl moiety emi103.2       wherein r7 is hydrogen, an alkyl group of up to 3 carbons, fluorine, chlorine or bromine;  x is ch2, o or s and mis the number 0 or 1, provided that when r is a thienyl moiety then m is 0;  and the tautomers of the above compounds.   24. a composition according to claim 23, wherein said 2-carbonyl-3-hydroxy-2-alkenonitrile is as defined in any one of claims 2 to 13.   25. a composition according to claim 23, wherein   ro    is the group: emi103.3        in which r1, r2, r3, r4 and r5 are hydrogen; m is the number 0; and r6 is'methyl.    26. a composition according to any of claims 23-25, in dosage unit form comprising from about   1-250    mg. per kg.   of body weight per dosage unit of active compound.    27. a method for preparing an anti-arthritic   compos-    ition useful for inhibiting the progression of arthritis, meliorating inflammation and/or inhibiting progressive joint deterioration in mammals, comprising incorporating into a pharmaceutical carrier or diluent of a 2-carbonyl-3-hydroxy- 2-alkenonitrile of the formula ii as defined in any of claims 23 to 25.    28. a method of producing compounds of   formula. 1,    as defined in claim 1, which comprises:  (a) reacting an acetonitrile of the formula: emi104.1       with a compound of the formula: emi104.2       wherein r , x, m and r6 are as defined above   andr8    is-o-alkyl or n(alkyl)2 and then hydrolyzing the product produced, and wherein, when   r8    is o-alkyl the resultant product may be treated with ammonia or a primary or secondary amine prior to said hydrolysis; or  (b) reacting the metal (me) enolate   salt of    an acetonitrile of the formula: emi104.3       with an acyl halide of the formula: emi104.4       wherein r  and r6 are as defined above;  or  (c) reacting an acyl halide of the formula:   emi105.1       with a metal (me)   nolate    salt of the formula: emi105.2       wherein x is ch2, m is the   number    0 or 1,   ro    and r are as defined above; or  (d) reacting a compound of the formula: emi105.3       with n,n-dimethylformamide dimethylacetal to produce an intermediate compound of the formula: emi105.4       reacting said intermediate with hydroxylamine hydrochloride and treating the resulting reaction mixture with a strong base, wherein   ro    and r6 are as defined above;  or  (e) reacting a compound of the formula:    ro    - x - h with a compound of the formula: emi105.5       in the presence of a proton scavenger such as a tertiary amine, to form an intermediate of the formula: emi105.6       wherein x is o or s and   ro    and r6 are as defined above, and further treating said intermediate with a proton scavenger such as a tertiary amine or alkoxide, thereby producing the corresponding final product; and  (f) if desired, forming pharmaceutically acceptable cation salts.   29. a method according to claim 28, wherein compounds are produced in accordance with the definitions in any one  of claims 2 to 13.   30. a   method    of producing compounds of formula viii as claimed in claim 14, which comprises reacting an acetonitrile of. the formula: emi106.1       with a compound of the formula:    r6, c(9r)3    wherein r, r1, r2,   r31    r4, r5, and r6 are as defined in formula viii, to produce a compound of formula viii in which y is or; and where desired, treating the compound where y is or with ammonia or a primary or secondary amine, thereby producing a compound of formula viii in which y is the group emi106.2       wherein r' and r" are as defined in formula viii.    31 a   method    of producing compounds of formula ix as   claimed    in claim 20, which comprises reacting a compound of the formula: emi106.3       with a compound of the formula: emi106.4       in the presence of a proton scavenger such   as-a    carbonate, bicarbonate or tertiary amine, wherein x and r1, r2, r3, r4 and r5 are as defined in formula ix.      32. a 2-carbonyl-3-hydroxy-2-alkenonitrile of the formula ii as defined in any one of claims 23-25 for use in inhibiting the progression of arthritis, meliorating   inflammation    and/or inhibiting progressive joint deterioration in mammals.  
</CLAIMS>
</TEXT>
</DOC>
